8-KShareholder Matters

BIOGEN INC. 8-K Report, Shareholder Vote Results (Jun 9, 2016)

Filed June 9, 2016For Securities:BIIB

Summary

Biogen Inc. (BIIB) held its Annual Meeting of Stockholders on June 8, 2016, and this 8-K filing details the final voting results. The meeting primarily focused on the election of directors, ratification of the independent auditor, and an advisory vote on executive compensation. All proposals presented to the stockholders were approved, indicating broad support for the company's current leadership and governance. Key outcomes include the election of eleven director nominees, with all receiving substantial "For" votes and minimal "Against" or "Abstention" votes, suggesting strong shareholder confidence in the Board's composition. Additionally, PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2016, reflecting continued reliance on their services. Finally, the advisory "Say-on-Pay" proposal also passed, indicating general shareholder approval of the company's executive compensation policies.

Key Highlights

  • 1All eleven director nominees were elected to the Board of Directors for a one-year term ending in 2017.
  • 2Each director nominee received a significant majority of "For" votes, with minimal "Against" or "Abstention" votes.
  • 3PricewaterhouseCoopers LLP was ratified as Biogen's independent registered public accounting firm for the fiscal year ending December 31, 2016.
  • 4The ratification of the independent auditor received overwhelming support, with a large majority of "For" votes.
  • 5The advisory vote on executive compensation (Say-on-Pay) was approved by stockholders.
  • 6The "Say-on-Pay" proposal also garnered substantial "For" votes, indicating general shareholder acceptance of compensation practices.

Frequently Asked Questions

The main topics voted on were the election of eleven nominees to the Board of Directors, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2016, and an advisory vote on executive compensation.

All eleven director nominees were elected to serve for a one-year term extending until the 2017 annual meeting of stockholders. Each nominee received a strong majority of "For" votes, with relatively few "Against" or "Abstention" votes.

Yes, stockholders ratified the selection of PricewaterhouseCoopers LLP as Biogen's independent registered public accounting firm for the fiscal year ending December 31, 2016, with a substantial majority of "For" votes.

Yes, the advisory vote on executive compensation, commonly known as "Say-on-Pay," was approved by the stockholders. The proposal received a significant majority of "For" votes.